A recent study in Florida tracked testicular cancer survivors treated with cisplatin-based chemotherapy over 14 years, finding that 78% suffer significant hearing difficulties affecting daily life. Published in the Journal of the American Medical Association Oncology, the research highlights how cisplatin, though effective against cancers, damages ear cells irreversibly, causing progressive hearing loss. Lead researchers emphasize the urgent need for routine hearing tests during and after chemotherapy to manage these effects better.
Chemotherapy Study Reveals Long-Term Hearing Issues in Cancer Survivors
![](https://affairsace-media.s3.ap-south-1.amazonaws.com/2024/07/02094222/ezgif.com-webp-to-jpg-converter-6.jpg)